U.S. National Library of MedicineNational Institutes of Health
Skip navigation
MedlinePlus Trusted Health Information for You
Contact Us FAQs Site Map About MedelinePlus
español

Reuters Health Information Logo

Soy protein beneficial in type 2 diabetics: study

Printer-friendly version Printer-friendly version

Reuters Health

Tuesday, April 22, 2008

NEW YORK (Reuters Health) - A diet rich in soy protein appears to have a lasting beneficial effect on the heart, blood vessels and kidneys of people with type 2 diabetes and kidney disease, Iranian researchers report in the journal Diabetes Care.

In a study, they found that soy protein consumption had a significant positive impact on cardiovascular risk factors and kidney-related biomarkers among type 2 diabetic patients with kidney disease.

Dr. Leila Azadbakht, of Isfahan University of Medical Sciences, and colleagues followed 41 patients with type 2 diabetes for 4 years. Twenty patients consumed a diet that was 35 percent animal protein, 35 percent textured soy protein and 30 percent vegetable protein.

The remaining 21 patients, who acted as controls, ate a diet that consisted of 70 percent animal protein and 30 percent vegetable protein. These patients received the same medical treatment as the soy group; the only difference was the absence of soy protein.

Compared with controls, patients who ate soy protein showed significantly lower levels of fasting blood sugar, total cholesterol, "bad" LDL cholesterol, and triglycerides.

In addition, circulating C-reactive protein levels, which signal inflammation in the body, were reduced as were levels of well known urinary markers of kidney disease.

Short-term studies have indicated such benefits with soy protein, but the researchers point out that this appears to be the first study that has demonstrated that these effects remain "stable with long-term consumption."

SOURCE: Diabetes Care, April 2008.


Reuters Health

Copyright © 2008 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

Related News:
More News on this Date

Related MedlinePlus Pages: